Sex and Individual Differences in Alcohol Intake Are Associated with Differences in Ketamine Self-Administration Behaviors and Nucleus Accumbens Dendritic Spine Density

Clinical and preclinical studies have shown that ketamine, an NMDA receptor antagonist, has promising therapeutic value for the treatment of alcohol use disorder (AUD). However, the maintenance of remission will ultimately require repeated infusions of ketamine, which may lead to abuse potential and...

Descripción completa

Detalles Bibliográficos
Autores principales: Strong, Caroline E., Wright, Katherine N., Kabbaj, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2019
Materias:
Confirmation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893233/
https://www.ncbi.nlm.nih.gov/pubmed/31740575
http://dx.doi.org/10.1523/ENEURO.0221-19.2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893233/
https://www.ncbi.nlm.nih.gov/pubmed/31740575
http://dx.doi.org/10.1523/ENEURO.0221-19.2019

Ejemplares similares